About: Caelyx

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Caelyx Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

pharmaceutical product

Attributes	Values
rdf:type	Item
description	pharmaceutical product (en) фармацевтичний продукт (uk)
rdfs:label	Caelyx (en) سيليكس (ar)
skos:prefLabel	Caelyx (en) سيليكس (ar)
name	Caelyx (en) سيليكس (ar)
instance of	wds:Q29004943-307FE557-C757-4EB8-85CA-0B532DE3875C wds:Q29004943-DA7250B7-6963-4227-8844-D71E7097E158
instance of	mixture pharmaceutical product
skos:altLabel	Liposomal Doxorubicin (en)
therapeutic area	wds:Q29004943-60F2011A-0C76-4F43-8959-D822F55CFEAE wds:Q29004943-AA289D23-B371-423B-AA0F-212E33828A31 wds:Q29004943-C2F1563B-60F4-4BA1-BEB7-526ABDE5E007 wds:Q29004943-DB14DAA1-3492-449D-A1BB-3B1D43B97FEB
therapeutic area	ovarian neoplasm breast cancer multiple myeloma Kaposi's sarcoma
has active ingredient	wds:Q29004943-C9B8A689-22C7-4522-AA84-E0CC853E9E33
PBS Drug Code	wds:Q29004943-47662568-F3DB-49C5-885D-B32AEC891C4C wds:Q29004943-68E99F4E-F5C0-4D24-9111-A5710EA590D4 wds:Q29004943-8CF11600-C49F-4615-A388-CBD4FB50ED17
has active ingredient	doxorubicin hydrochloride
PBS Drug Code	6249X 4364Q 7230M
European Medicines Agency product number	wds:Q29004943-491BF473-0C80-4170-8E76-01F059DB7E9C
European Medicines Agency product number	EMEA/H/C/000089
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q29004943
is research intervention of	RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma TACE as an Adjuvant Therapy After Hepatectomy for HCC Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement Rituximab and ABVD for Hodgkin's Patients Hyper-CVAD Plus Nelarabine in Untreated T-ALL/Lymphoblastic Lymphoma A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011) A Safety and Pharmacokinetics (PK) Study of Venetoclax in Participants With Non-Hodgkin's Lymphoma Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3A Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients Combination Chemotherapy and Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma MabThera (Rituximab) in Combination With CHOP (or CHOP-like) Chemotherapy in Patients With Aggressive B-Cell Lymphoma FIL Study on ABVD DD-DI as Upfront Therapy in HL. Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2 Octreotide and Doxorubicin in Treating Patients With Advanced Cancer Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity APX005M, Doxorubicin, Olaratumab in Advanced Sarcoma Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's Syndrome Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL Patients Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma Hyper-CVAD Regimen in Sequential Combination With Blinatumomab as Frontline Therapy for Adults With B-Cell Lineage Acute Lymphocytic Leukemia A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Two Cycles of PAD Combination by AHCT in MM A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma A Phase I/II Trial of VR-CHOP in Lymphoma Patients A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer PET-Directed Therapy With Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Classical Hodgkin Lymphoma Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer A Scandinavian Sarcoma Group Protocol for Patients With High-risk Soft Tissue Sarcoma of the Extremities and Trunk Wall Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software